Randal W. Scott
Director · 2 filings · Latest: May 15, 2026
BridgeBio Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BBIO | Randal W. Scott | Director | May 15, 2026 | Sale | $67.15 | 10,000 | $671.5K | 11,589 | |
BBIO | Randal W. Scott | Director | May 15, 2026 | Option Exercise | $16.75 | 10,000 | $167.5K | 21,589 | |
BBIO | Randal W. Scott | Director | Feb 17, 2026 | Sale | $75.46 | 10,000 | $754.6K | 11,589 | |
BBIO | Randal W. Scott | Director | Feb 17, 2026 | Option Exercise | $16.75 | 10,000 | $167.5K | 21,589 | |
BBIO | RANDAL SCOTT | — | Feb 17, 2026 | Proposed Sale | $75.25 | 20,000 | $1.5M | — | |
BBIO | RANDAL SCOTT | — | Nov 17, 2025 | Proposed Sale | $66.39 | 10,000 | $663.9K | — |